Astrana Health (NASDAQ:ASTH) Reaches New 1-Year High – Here’s What Happened

Posted by Brenda Bartman on May 15th, 2026

Astrana Health, Inc. (NASDAQ:ASTH – Get Free Report)’s share price reached a new 52-week high during trading on Wednesday . The stock traded as high as $39.92 and last traded at $39.7950, with a volume of 333012 shares changing hands. The stock had previously closed at $39.01.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on ASTH shares. Needham & Company LLC boosted their price target on shares of Astrana Health from $30.00 to $41.00 and gave the company a “buy” rating in a report on Friday, May 8th. Truist Financial boosted their price target on shares of Astrana Health from $38.00 to $47.00 and gave the company a “buy” rating in a report on Thursday. BTIG Research boosted their price target on shares of Astrana Health from $40.00 to $50.00 and gave the company a “buy” rating in a report on Friday, May 8th. Zacks Research upgraded shares of Astrana Health from a “strong sell” rating to a “hold” rating in a report on Wednesday, March 11th. Finally, Robert W. Baird set a $45.00 price target on shares of Astrana Health in a report on Friday, May 8th. Six investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, Astrana Health presently has a consensus rating of “Moderate Buy” and an average target price of $43.14.

Get Our Latest Report on Astrana Health

Astrana Health Stock Performance

The stock has a market cap of $2.13 billion, a price-to-earnings ratio of 62.72 and a beta of 0.98. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.40 and a current ratio of 1.35. The stock’s 50-day simple moving average is $29.05 and its two-hundred day simple moving average is $25.88.

Astrana Health (NASDAQ:ASTH – Get Free Report) last released its earnings results on Thursday, May 7th. The company reported $0.74 earnings per share for the quarter, topping analysts’ consensus estimates of $0.29 by $0.45. The firm had revenue of $965.10 million during the quarter, compared to analyst estimates of $949.21 million. Astrana Health had a net margin of 0.86% and a return on equity of 9.22%. The business’s revenue was up 55.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.42 EPS. Analysts forecast that Astrana Health, Inc. will post 1.25 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Diamond Hill Capital Management Inc. lifted its position in Astrana Health by 33.0% during the 3rd quarter. Diamond Hill Capital Management Inc. now owns 361,264 shares of the company’s stock worth $10,242,000 after acquiring an additional 89,733 shares during the last quarter. Insight Wealth Strategies LLC acquired a new position in shares of Astrana Health during the fourth quarter valued at about $3,514,000. 325 Capital LLC raised its position in shares of Astrana Health by 34.6% during the third quarter. 325 Capital LLC now owns 1,193,953 shares of the company’s stock valued at $33,849,000 after buying an additional 307,037 shares during the last quarter. Quantbot Technologies LP raised its position in shares of Astrana Health by 384.4% during the third quarter. Quantbot Technologies LP now owns 40,659 shares of the company’s stock valued at $1,153,000 after buying an additional 32,265 shares during the last quarter. Finally, SG Americas Securities LLC acquired a new position in shares of Astrana Health during the third quarter valued at about $1,062,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

About Astrana Health

(Get Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.